Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Greer

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Experimental Hematology|January 25, 2012
Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimenNishitha Reddy, John P Greer, Stacey Goodman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignanciesMadan Jagasia, William B Clark, Kristin D Brown-Gentry, et al.
Cytotherapy|July 1, 2010
Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantationSara K Tedeschi, Madan Jagasia, Brian G Engelhardt, et al.
British Journal of Haematology|July 14, 2016
Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planningVan T Nguyen, Priyanka A Pophali, Judy P Tsai, et al.
Journal for Immunotherapy of Cancer|February 28, 2017
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapyEileen Shiuan, Kathryn E Beckermann, Alpaslan Ozgun, et al.
Bone Marrow Transplantation|March 16, 2018
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemiaKatie S Gatwood, Kathryn A Culos, Laura A Binari, et al.
Journal of Hematology|March 1, 2021
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell TransplantDilan A Patel, Karina A Mendoza, Heidi Chen, et al.
Leukemia & Lymphoma|April 12, 2003
Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classificationEdward R Arrowsmith, William R Macon, Marsha C Kinney, et al.
Blood|June 2, 2011
Genetic variation in recipient B-cell activating factor modulates phenotype of GVHDWilliam B Clark, Kristin D Brown-Gentry, Dana C Crawford, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2016
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 SignalingRomany A N Johnpulle, Sophie Paczesny, Dae Kwang Jung, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Experimental Hematology|January 25, 2012
Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimenNishitha Reddy, John P Greer, Stacey Goodman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 20, 2011
Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignanciesMadan Jagasia, William B Clark, Kristin D Brown-Gentry, et al.
Cytotherapy|July 1, 2010
Early lymphocyte reconstitution is associated with improved transplant outcome after cord blood transplantationSara K Tedeschi, Madan Jagasia, Brian G Engelhardt, et al.
British Journal of Haematology|July 14, 2016
Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planningVan T Nguyen, Priyanka A Pophali, Judy P Tsai, et al.
Journal for Immunotherapy of Cancer|February 28, 2017
Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapyEileen Shiuan, Kathryn E Beckermann, Alpaslan Ozgun, et al.
Bone Marrow Transplantation|March 16, 2018
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemiaKatie S Gatwood, Kathryn A Culos, Laura A Binari, et al.
Journal of Hematology|March 1, 2021
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell TransplantDilan A Patel, Karina A Mendoza, Heidi Chen, et al.
Leukemia & Lymphoma|April 12, 2003
Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classificationEdward R Arrowsmith, William R Macon, Marsha C Kinney, et al.
Blood|June 2, 2011
Genetic variation in recipient B-cell activating factor modulates phenotype of GVHDWilliam B Clark, Kristin D Brown-Gentry, Dana C Crawford, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2016
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 SignalingRomany A N Johnpulle, Sophie Paczesny, Dae Kwang Jung, et al.
Pageof 5